The CXCL12/CXCR4 axis has been reported to be a key signalling axis for tumour growth and metastasis through the activation of multiple pathways, such as the p38, ERK1/2 and SAPK/JNK pathways.37, 38. This evidence concerns the gene MAPK9 and neoplasm.